Full Text View
Tabular View
No Study Results Posted
Related Studies
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
This study has been completed.
Study NCT01212471   Information provided by Bausch & Lomb Incorporated

First Received on September 28, 2010.   Last Updated on March 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dry Eye Syndrome
Additional conditions recognized in this trial
Dry Eye Syndromes
Eye Diseases
Keratoconjunctivitis Sicca
More general conditions related to this trial
Conjunctival Diseases
Conjunctivitis
Corneal Diseases
Keratitis
Keratoconjunctivitis
Lacrimal Apparatus Diseases
Interventions listed in this trial
Bromfenac Ophthalmic Solution A
Bromfenac Ophthalmic Solution B
Placebo Comparator
Additional drug interventions recognized in this trial
Bromfenac
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Bausch & Lomb Incorporated


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services